Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
5,28 EUR | -0,19 % |
|
-10,02 % | +20,93 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 58 | 13/09/10 | |
Jinchul Jeong
DFI | Director of Finance/CFO | - | - |
Michael Smith
CMP | Compliance Officer | - | - |
Brent Gardner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jebediah Ledell
COO | Chief Operating Officer | 49 | 01/12/21 |
Stefanie Solomon
CMP | Compliance Officer | - | - |
Anisha Wharton
LAW | General Counsel | - | 01/01/21 |
Danielle Holland
LAW | General Counsel | - | - |
David Crist
SAM | Sales & Marketing | - | 19/10/20 |
Corporate Officer/Principal | - | 01/12/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 58 | 13/09/10 | |
Jaywin Lee
BRD | Director/Board Member | - | 19/01/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 34 763 127 | 34 693 418 ( 99,80 %) | 0 | 99,80 % |
Información de la empresa
AVEO Pharmaceuticals, Inc.
1 Marina Park Drive 12th floor
02210, Boston
+857 400 0101
http://www.aveooncology.com![Dirección AVEO Pharmaceuticals, Inc.(VPA)](https://cdn.zonebourse.com/static/address/50916923.png)
Varia. 1 de ene. | Capi. | |
---|---|---|
+4,57 % | 96,72 mil M | |
+5,66 % | 41,43 mil M | |
-12,76 % | 32,7 mil M | |
+80,99 % | 29,06 mil M | |
-15,88 % | 15,38 mil M | |
-9,40 % | 12,97 mil M | |
-12,22 % | 11,36 mil M | |
+183,25 % | 9898,13 M | |
+3,60 % | 8927,64 M |
- Bolsa de valores
- Acciones
- Acción AVEO
- Acción VPA
- Empresa AVEO Pharmaceuticals, Inc.